Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
October 8, 2016
Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
John A Halsall, Bryan M Turner
BMC Genetics
|
May 1, 2015
Immunolabelling of human metaphase chromosomes reveals the same banded distribution of histone H3 isoforms methylated at lysine 4 in primary lymphocytes and cultured cell lines
Edith Terrenoire, John A Halsall, Bryan M Turner
Epigenetics & Chromatin
|
September 19, 2015
Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response
John A Halsall, Nil Turan, Maaike Wiersma, et al.
Dermato-Endocrinology
|
January 5, 2010
The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma
John A Halsall, Joy E Osborne, Michael P Epstein, et al.
Nature Genetics
|
November 29, 2011
Relative overexpression of X-linked genes in mouse embryonic stem cells is consistent with Ohno's hypothesis
Hong Lin, John A Halsall, Philipp Antczak, et al.
Epigenetics & Chromatin
|
November 30, 2016
Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes
Maaike Wiersma, Marianne Bussiere, John A Halsall, et al.
Scientific Reports
|
February 5, 2021
Histone modifications form a cell-type-specific chromosomal bar code that persists through the cell cycle
John A Halsall, Simon Andrews, Felix Krueger, et al.
Epigenetics & Chromatin
|
May 3, 2013
The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
Elsa Boudadi, Hannah Stower, John A Halsall, et al.
Clinical Epigenetics
|
November 10, 2020
Morphine leads to global genome changes in H3K27me3 levels via a Polycomb Repressive Complex 2 (PRC2) self-regulatory mechanism in mESCs
Iraia Muñoa-Hoyos, John A Halsall, Manu Araolaza, et al.
Melanoma Research
|
July 14, 2018
Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity
Peter E Hutchinson, John A Halsall, Silvia Popovici, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
October 8, 2016
Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
John A Halsall, Bryan M Turner
BMC Genetics
|
May 1, 2015
Immunolabelling of human metaphase chromosomes reveals the same banded distribution of histone H3 isoforms methylated at lysine 4 in primary lymphocytes and cultured cell lines
Edith Terrenoire, John A Halsall, Bryan M Turner
Epigenetics & Chromatin
|
September 19, 2015
Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response
John A Halsall, Nil Turan, Maaike Wiersma, et al.
Dermato-Endocrinology
|
January 5, 2010
The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma
John A Halsall, Joy E Osborne, Michael P Epstein, et al.
Nature Genetics
|
November 29, 2011
Relative overexpression of X-linked genes in mouse embryonic stem cells is consistent with Ohno's hypothesis
Hong Lin, John A Halsall, Philipp Antczak, et al.
Epigenetics & Chromatin
|
November 30, 2016
Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes
Maaike Wiersma, Marianne Bussiere, John A Halsall, et al.
Scientific Reports
|
February 5, 2021
Histone modifications form a cell-type-specific chromosomal bar code that persists through the cell cycle
John A Halsall, Simon Andrews, Felix Krueger, et al.
Epigenetics & Chromatin
|
May 3, 2013
The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
Elsa Boudadi, Hannah Stower, John A Halsall, et al.
Clinical Epigenetics
|
November 10, 2020
Morphine leads to global genome changes in H3K27me3 levels via a Polycomb Repressive Complex 2 (PRC2) self-regulatory mechanism in mESCs
Iraia Muñoa-Hoyos, John A Halsall, Manu Araolaza, et al.
Melanoma Research
|
July 14, 2018
Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity
Peter E Hutchinson, John A Halsall, Silvia Popovici, et al.
Page
of 2